- Home
- ELDN vs HNVR Comparison
ELDN vs HNVR Comparison
Compare ELDN & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- HNVR
- Stock Information
- Founded
- ELDN 2004
- HNVR 2008
- Country
- ELDN United States
- HNVR United States
- Employees
- ELDN N/A
- HNVR N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- HNVR Commercial Banks
- Sector
- ELDN Health Care
- HNVR Finance
- Exchange
- ELDN Nasdaq
- HNVR Nasdaq
- Market Cap
- ELDN 178.4M
- HNVR 143.6M
- IPO Year
- ELDN N/A
- HNVR 2022
- Fundamental
- Price
- ELDN $2.89
- HNVR $23.11
- Analyst Decision
- ELDN Strong Buy
- HNVR Buy
- Analyst Count
- ELDN 1
- HNVR 1
- Target Price
- ELDN $16.00
- HNVR $22.00
- AVG Volume (30 Days)
- ELDN 160.2K
- HNVR 27.4K
- Earning Date
- ELDN 05-20-2025
- HNVR 04-23-2025
- Dividend Yield
- ELDN N/A
- HNVR 1.73%
- EPS Growth
- ELDN N/A
- HNVR N/A
- EPS
- ELDN N/A
- HNVR 1.30
- Revenue
- ELDN N/A
- HNVR $65,041,000.00
- Revenue This Year
- ELDN N/A
- HNVR N/A
- Revenue Next Year
- ELDN N/A
- HNVR $15.80
- P/E Ratio
- ELDN N/A
- HNVR $17.77
- Revenue Growth
- ELDN N/A
- HNVR 1.13
- 52 Week Low
- ELDN $2.00
- HNVR $15.92
- 52 Week High
- ELDN $5.54
- HNVR $27.14
- Technical
- Relative Strength Index (RSI)
- ELDN 40.93
- HNVR 56.86
- Support Level
- ELDN $2.85
- HNVR $22.37
- Resistance Level
- ELDN $3.51
- HNVR $23.94
- Average True Range (ATR)
- ELDN 0.27
- HNVR 0.77
- MACD
- ELDN -0.01
- HNVR 0.12
- Stochastic Oscillator
- ELDN 5.63
- HNVR 74.93
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.